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Introduction 
Mucous membrane pemphigoid (MMP) with 
ocular involvement, also referred to as ocular 
cicatricial pemphigoid (OCP), is a rare, 
autoimmune blistering disease that can ultimately 
result in severe vision loss. We present a particular 
patient with recalcitrant ocular MMP who received 
bilateral keratoprostheses, which helped to 
restore his vision and ultimately his quality of life. 
Case Synopsis 
A 64-year-old man developed mild symptoms of 
blurry vision and dry eyes in 2000. He underwent 
uneventful cataract surgery in 2008, which 
improved his vision somewhat, but he was 
subsequently noted to have bilateral 
symblepharon and conjunctivalization of his 
corneas, limiting both his eye movement and his 
vision. He began treatment for suspected ocular 
MMP with dapsone in 2012 and was ultimately 
diagnosed with MMP by an ophthalmology 
consultant based on conjunctival biopsy in 2014. 
Indirect immunofluorescence for IgG 
autoantibodies against the basement membrane 
zone and ELISA for anti-BP180, anti-BP230, and 
anti-type VII collagen autoantibodies were 
negative. Unfortunately, at that point he had 
already developed advanced corneal involvement; 
therefore, he underwent anterior segment 
reconstruction of the right eye with PROKERA® 
ring placement in 2014. He aggressively scarred 
over the PROKERA® ring, which ultimately had to 
be dissected out one week later. The following 
year he received a corneal transplant with 
keratoprosthesis (K-pro lens) placement for 
corneal involvement of the left eye, which 
improved his vision to 20/40 at only 32 days 
postoperatively. He was referred to the 
dermatology department for further medical 
management and achieved stabilization with 
Abstract 
Mucous membrane pemphigoid (MMP) with 
ocular involvement, also referred to as ocular 
cicatricial pemphigoid, is a rare, autoimmune 
blistering disease that can have devastating 
effects for patients. The resulting corneal 
neovascularization, recurrent corneal abrasions, 
and ulceration can ultimately result in severe 
vision loss. We present a 64-year-old man with 
recalcitrant ocular MMP and consequently 
advanced corneal involvement that received 
bilateral keratoprostheses. This case highlights an 
aggressive but successful placement of bilateral 
keratoprostheses in recalcitrant ocular MMP, 
which restored his vision and ultimately his quality 
of life. 
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mycophenolate mofetil 1gm daily, one round of 
rituximab infusions following the rheumatoid 
arthritis protocol (1gm repeated in two weeks), 
and tacrolimus eye drops. In 2018, a K-pro lens 
was placed in the right eye resulting in improved 
vision, from 20/500 to 20/60 (Figure 1). 
He is currently maintained on mycophenolate 
mofetil 1gm daily as well as prednisolone, 
moxifloxacin, latanoprost, and tacrolimus eye 
drops. Since his last visit he developed glaucoma 
of the left eye, a known complication following K-
pro lens placement [1]. This has caused a decrease 
in vision in his left eye but he currently maintains 
20/60 vision in the right eye. 
 
Case Discussion 
Known target antigens for MMP include BP180, 
BP230, laminin 332, laminin 6, collagen VII, and 
integrin β4, alpha6 [2]. Previous reports suggest 
integrin beta 4 antibodies are more specific for 
OCP, although these were not assessed in this 
case [3]. Use of combined serological testing may 
be appropriate when diagnosing MMP [4]. 
 
Conclusion 
MMP with ocular involvement is a treatment 
challenge with potential for scarring and 
blindness. There are no available therapeutic 
options to reverse scarring and fibrosis once 
formed. Therefore, early detection and treatment 
is essential to prevent devastating complications 
[5]. This case highlights an aggressive but 
successful placement of bilateral 
keratoprostheses in a patient with advanced, 
recalcitrant ocular MMP, which restored his vision 
and ultimately his quality of life. 
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Figure 1. Successful placement of bilateral keratoprostheses in a patient with recalcitrant ocular cicatricial pemphigoid (OCP), 
restoring his vision (OS [oculus sinister] 20/40, OD [oculus dexter] 20/60) and ultimately his quality of life 
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